Dalbavancin, CAS 171500-79-1

Product Description: Dalbavancin (MDL-63397) is a semisynthetic lipoglycopeptide antibiotic with potent bactericidal activity against Gram-positive bacteria. Dalbavancin inhibits Staphylococcus aureus and Bacillus anthracis with MIC90s of 0.06 μg/mL and 0.25 μg/mL, respectively[1][2].

Applications: COVID-19-immunoregulation

Formula: C88H100Cl2N10O28

Citations: Cell Res. 2021 Jan;31(1):17-24./Enferm Infec Micr Cl. 30 July 2022./Eur J Orthop Surg Traumatol. 2023 Jun 4./Sci Rep. 2022 Sep 26;12(1):16001./Antivir Res. 2020 Jun;178:104786./Cell Res. 2021 Jan;31(1):17-24./The Journal of Antibiotics . 2019 Feb;72(2):114-117.

References: [1]Heine HS, et al. Activity of dalbavancin against Bacillus anthracis in vitro and in a mouse inhalation anthrax model. Antimicrob Agents Chemother. 2010 Mar;54(3):991-6./[2]Bennett JW, et al. Dalbavancin in the treatment of complicated skin and soft-tissue infections: a review. Ther Clin Risk Manag. 2008 Feb;4(1):31-40.

CAS Number: 171500-79-1

Molecular Weight: 1816.69

Research Area: Infection

Solubility: 10 mM in DMSO

Target: Antibiotic;Bacterial

• Artikelnummer: MEXHY-17586A-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-17586A-10
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK